A person’s genes can shape the types of microbes that reside in the human gut independent of the environment a person lives in, according to a Cornell-led study.
ZYMtronix, a startup company with roots in Cornell-developed technology and operating in Cornell’s McGovern Center for business development, has signed an agreement with Codexis, a major producer of pharmaceutical enzymes.
Cornell’s Translational Research Institute for Pain in Later Life has received a five-year, $1.95 million renewal grant from the National Institute on Aging.
Academic experts and industry insiders will gather at Cornell on Dec. 8 for a global summit to discuss new approaches to emerging food system challenges.
The authors of “Retirement and the Hidden Epidemic: The Complex Link Between Aging, Work Disengagement and Substance Misuse – and What To Do About It” presented their findings in New York City Oct. 20.
Campus and local health officials said Oct. 21 that there is little risk locally for an Ebola outbreak, but training, protocols for handling cases and Cornell travel restrictions are part of their readiness efforts.
